The role of renal microvascular disease and interstitial inflammation in salt-sensitive hypertension

Hypertension Research

Volumn 33, Issue 10, 2010, Pages 975-980

  Rodriguez Iturbe, Bernardo ^a   Johnson, Richard J ^b  

^a HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

interstitial inflammation; oxidative stress; pressure natriuresis; T cells

Indexed keywords

ARTERIOSCLEROSIS; AUTOIMMUNITY; AUTOREGULATION; CELLULAR DISTRIBUTION; ESSENTIAL HYPERTENSION; GENE MUTATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTERSTITIUM; KIDNEY FIBROSIS; KIDNEY INJURY; MACROPHAGE; MICROANGIOPATHY; MICROVASCULARIZATION; NATRIURESIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; SALT INTAKE; SODIUM EXCRETION; T LYMPHOCYTE; THYMECTOMY;

ANIMALS; HSP72 HEAT-SHOCK PROTEINS; HUMANS; HYPERTENSION; KIDNEY DISEASES; MICE; MICROVESSELS; MODELS, ANIMAL; NATRIURESIS; NEPHRITIS, INTERSTITIAL; OXIDATIVE STRESS;

EID: 77957717868     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.148     Document Type: Review

References (87)

1. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet 2003; 361: 1629-1641.
2. He FJ, Macgregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2008; 23: 363-384.
3. WHO. The World Health Report 2002. Reducing risks, promoting healthy life. 2002. http://www.who.int/whr/2002/en/.
4. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362: 590-599.
5. Palar K, Sturm R. Potential societal savings from reduced sodium consumption in the US adult population. Am J Health Promot 2009; 24: 49-57.
6. Borst JGG, Borst-de Geuss A. Hypertension explained by Starling's theory of circulatory homoeostasis. Lancet 1963; 1: 677-682.
7. Guyton AC, Coleman TG, Cowley Jr AW, Scheel KW, Manning Jr RD, Norman Jr RA. Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972; 52: 584-594.
8. Dahl LK, Heine M, Thompson K. Genetic influence of renal homografts on the blood pressure of rats from different strains. Proc Soc Exp Biol Med 1972; 140: 852-856.
9. Bianchi G, Fox U, Di Francesco gF, Bardi U, Radice M. The hypertensive role of the kidney in spontaneously hypertensive rats. Clin Sci Mol Med 1973; 45(Suppl 1): 135S-139S.
10. Heller J, Schubert G, Havlickova J, Thurau K. The role of the kidney in the development of hypertension: a transplantation study in the Prague hypertensive rat. Pflügers Arch 1993; 425: 208-212.
11. Morgan DA, DiBona GF, Mark AL. Effects of interstrain renal transplantation on NaCl-induced hypertension in Dahl rats. Hypertension 1990; 15: 436-442.
12. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Diethelm AG. Remission of essential hypertension after renal transplantation. N Engl J Med 1983; 309: 1009-1015.
13. Weinberg M, Fineberg N. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension 1991; 18: 67-71.
14. Rodriguez-Iturbe B, Romero F, Johnson RJ. Pathophysiologic mechanisms of salt-dependent hypertension. Am J Kidney Dis 2007; 50: 655-672.
15. Guyton AC. Blood pressure control: special role of the kidneys and body fluids. Science 1991; 252: 1813-1816.
16. Gull W, Sutton H. On the pathology of the morbid state commonly called chronic Brights disease with contracted kidney 'arterio-capillary fibrosis'. Med Chir Trans 1872; 55: 325-371.
17. Johnson G. The anatomy of Bright's disease: the arterio-capillary fibrosis of Sir William Gull and Dr. Sutton. Br Med J 1972; 1: 604-605.
18. Folkow B. Structure and function of the arteries in hypertension. Am Heart J 1987; 114: 938-948.
19. Mahomed FA. The etiology of Bright's disease and the prealbuminuric state. Med Chir Tr a n s 1874; 39: 197-228.
20. Moritz A, Oldt M. Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 1937; 13: 679-728.
21. Goldblatt H. The renal origin of hypertension. Physiol Rev 1947; 27: 120-165.
22. Kimmelstiel P, Wilson C. Benign and malignant hypertension and nephrosclerosis. A clinical and pathological study. Am J Pathol 1936; 12: 45-81.
23. Wilson C. Renal factors in the production of hypertension. Lancet 1953; 1: 579-584, 632-638.
24. Castelman B, Smithwick RH. The relation of vascular disease to the hypertensive state. Based on a study of renal biopsies from one hundred hypertensive patients. J Am Med Assoc 1943; 121: 1256-1261.
25. Goldblatt H, Lynch J, Hanzal R, Summerville W. Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934; 59: 347-379.
26. Perera GA. Hypertensive vascular disease; description and natural history. J Chronic Dis 1955; 1: 33-42.
27. Sommers SC, Relman AS, Smithwick RH. Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol 1958; 34: 685-715.
28. Saltz M, Sommers SC, Smithwick RH. Clinicopathologic correlations of renal biopsies from essential hypertensive patients. Circulation 1957; 16: 207-212.
29. Johnson RJ, Herrera J, Schreiner G, Rodríguez-Iturbe B. Acquired and subtle renal injury as a mechanism for salt-sensitive hypertension: bridging the hypothesis of Goldblatt and Guyton. N Engl J Med 2007; 346: 913-923.
30. Johnson RJ, Schreiner G. Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int 1997; 52: 1169-1179.
31. Faubert PF, Chou SY, Porush JG. Regulation of papillary plasma flow by angiotensin II. Kidney Int 1987; 32: 472-478.
32. Myers BD, Deen WM, Brenner BM. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule reabsorption in the rat. Circ Res 1975; 37: 101-110.
33. Johnson RJ, Gordon KL, Suga S, Duijvestijn AM, Griffin K, Bidani A. Renal injury and salt-sensitive hypertension after exposure to catecholamines. Hypertension 1999; 34: 151-159. (Pubitemid 29325734)
34. Andoh TF, Johnson RJ, Lam T, Bennet WM. Subclinical renal injury induced by cyclosporine exposure is associated with salt-sensitive hypertension. Am J Transplant 2001; 1: 222-227.
35. Raqy PE, Suga S, Lin X-H, Huang X, Johnson RJ. Chronic potassium depletion induces renal injury, salt-sensitivity and hypertension in young rats. Kidney Int 2001; 59: 1850-1858.
36. Bohle A, Muller G, Whermann M, Mackensen-Haen S, Xiao J-C. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies and chronic interstitial nephritides. Kidney Int 1996; 49(Suppl 54): S2-S9.
37. Svendsen UG. Evidence for an initial, thymus independent and a chronic, thymus-dependent phase of DOCA and salt hypertension in mice. Acta Path Microbiol Scand A 1976; 84: 523-528.
38. Svendsen UG. The importance of thymus in the pathogenesis of the chronic phase of hypertension in mice following partial infarction of the kidney. Acta Pathol Microbiol Scand A 1977; 85: 539-547.
39. Norman Jr RA, Galloway PG, Dzielak DJ, Huang M. Mechanisms of partial renal infarct hypertension. J Hypertens 1988; 6: 397-403.
40. Bendich A, Belisle EH, Strausser HR. Immune system modulation and its effects on blood pressure of the spontaneously hypertensive male and female rat. Biochem Biophys Res Commun 1981; 99: 600-607.
41. Takeichi N, Suzuli F, Kobayashi H. Immunologic depression in spontaneously hypertensive rats. Clin Exp Immunol 1980; 40: 120-126.
42. Rodríguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 2001; 59: 2222-2232.
43. Quiroz Y, Pons H, Gordon KL, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ, Rodríguez-Iturbe B. Mycophenolate mofetil prevents the salt-sensitive hypertension resulting from short-term nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 2001; 281: F38-F47.
44. Alvarez V, Quiroz Y, Nava M, Pons H, Rodríguez-Iturbe B. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 2002; 283: F1132-F1141.
45. Bataillard P, Freiche J-C, Vincent M, Touraine J-L, Sassard JU. Effects of neonatal thymectomy on blood pressure and immunological characteristics of the genetically hypertensive rats of the Lyon strain. J Hypertens 1986; 4(Suppl 3): 5455-5467.
46. Svendsen UG. Spontaneous hypertension and hypertensive vascular disease in the NZB strain of mice. Acta Pathol Microbiol Scand A 1977; 85: 548-554.
47. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204: 2449-2460. (Pubitemid 47529329)
48. Lee DL, Sturgis LC, Labazi H, Osborne Jr JB, Fleming C, Pollock JS, Manhiani M, Imig JD, Brands MW. Angiotensin II hypertension in attenuated in interleukin-g knockout mice. Am J Physiol Heart Circ Physiol 2006; 290: H935-H940.
49. Rodríguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND. Early and sustained inhibition of nuclear factor kappa B prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther 2005; 315: 51-57.
50. Müller DN, Dechend R, Mervaal EMA, Park J-K, Schmidt F, Fiebler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC. NF-kB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000; 35(Part 2): 193-201.
51. Rodŕguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chávez M, Herrera-Acosta J, Johnson RJ, Pons HA. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol. 2002. 282. F191-F201.
52. Mattson DL, James L, Berdan EA, Meister CJ. Immune suppression attenuates hypertension and renal disease in Dahl salt-hypertensive rats. Hypertension 2006; 48: 149-156.
53. Tian N, Gu JW, Braddy SJ, Rose RA, Hughson MD, Manning Jr RD. Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 2007; 292: H1018-H1025.
54. Bravo Y, Quiroz Y, Ferrebuz A, Vaziri ND, Rodríguez-Iturbe B. Mycophenolate mofetil administration reduces renal inflammation, oxidative stress and arterial pressure in rats with lead-induced hypertension. Am J Physiol Renal Physiol 2007; 297: F616-F623.
55. Vanegas V, Ferrebuz A, Quiroz Y, Rodríguez-Iturbe B. Hypertension in Page (cellophane wrapped) kidney is due to interstitial nephritis. Kidney Int 2005; 68: 1161-1170.
56. Stewart T, Jung FF, Manning J, Vehaskari VM. Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension. Kidney Int 2005; 68: 2180-2188.
57. Herrera J, Ferrebuz A, MacGregor EG, Rodríguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol 2006; 17(Suppl 3): S218-S225.
58. Mervaala E, Müller DN, Park J-K, Dechend R, Schmidt F, Fiebler A, Bieringer M, Breu V, Ganten D, Haller H, Luft FC. Cyclosporin A protects against Angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensiogen genes. Hypertension 2000; 35: 360-366.
59. Khraibi AA, Norman Jr RA, Dzielak DJ. Chronic immunosuppression attenuates hypertension in Okamoto spontaneously hypertensive rats. Am J Physiol 1984; 247(Heart Circ Physiol 16): H722-H726.
60. Rodríguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet improves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 2003; 41: 341-346.
61. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 2001; 37: 781-786.
62. Nava M, Quiroz Y, Vaziri ND, Rodríguez-Iturbe B. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2003; 284: F447-F454. (Pubitemid 36227905)
63. Hughson MD, Gobe GC, Hoy WE, Manning Jr RD, Douglas-Denton R, Bertram JF. Associations of glomerular number and birth weight with clinicopathological features of African Americans and whites. Am J Kidney Dis 2008; 52: 18-28.
64. Machnik A, Dahlmann A, Kopp C, Goss J, Wagner H, van Rooijen N, Eckardt KU, Müller DN, Park JK, Luft FC, Kerjaschki D, Titze J. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats. Hypertension 2010; 55: 755-761.
65. Vaziri ND, Rodriguez-Iturbe B. Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2006; 2: 582-593.
66. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39: 316-322.
67. Cowley AW. Renal medullary oxidative stress, pressure-natriuresis and hypertension. Hypertension 2008; 52: 777-786.
68. Makino A, Skelton MM, Zou AP, Roman RJ, Cowley Jr AW. Increased renal medullary oxidative stress produces hypertension. Hypertension 2002; 39: 667-672.
69. Kurokawa K. Kidney, salt and hypertension: how and why. Kidney Int 1996; 49(Suppl 55): S46-S51.
70. Touyz RM, He G, El Mabroul M, Schiffrin EL. p38 MAP kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY. Hypertension 2001; 37: 574-580.
71. Sánchez-Lozada LG, Tapia E, Johnson RJ, Rodŕguez-Iturbe B, Herrera-Acosta J. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointer-stitial inflammation. Kidney Int 2003; 64(Suppl 86): S9-S14.
72. Sharma K, Cook A, Smith M, Valancius C, Inscho EW. TGF-beta impairs renal autoregulation via generation of ROS. Am J Physiol Renal Physiol 2005; 288: F1069-F1077.
73. Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage. Implications for therapy. Hypertension 2004; 44: 595-601.
74. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 2004; 286: F606-F616.
75. Tuttle RS, Boppana DP. Antihypertensive effect of interleukin 2. Hypertension 1990; 15: 89-94.
76. Kristensen BO, Andersen PL. Autoantibodies in untreated and treated essential hypertension. Acta Med Scand 1978; 203: 55-59.
77. Dzielak DJ. AIDS, lupus, rheumatoid arthritis-hypertension? Hypertension 1990; 15: 95-96.
78. Lodwick D, Kaiser MA, Harris J, Privat P, Vincent M, Sassard J, Samani NJ. Failure of the heat-shock protein 70 locus to cosegregate with blood pressure in spontaneously hypertensive rat x Wistar-Kyoto rat cross. J Hypertens 1993; 11: 1047-1051.
79. Hamet P, Malo D, Hashimoto T, Tremblay J. Heat stress genes in hypertension. J Hypertens Suppl 1990; 8: S47-S52.
80. Kaufmann SHE. Heat shock proteins and the immune response. Immunol Today 1990; 11: 129-136.
81. Young RA. Stress proteins and immunology. Annu Rev Immunol 1990; 8: 401-420.
82. Ishizaka N, Aizawa T, Ohno M, Usui Si S, Mori I, Tang SS, Ingelfinger JR, Kimura S, Nagai R. Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II. Hypertension 2002; 39: 122-128.
83. Bravo J, Quiroz Y, Pons H, Parra G, Herrera-Acosta J, Johnson RJ, Rodŕguez-Iturbe B. Vimentin and heat shock protein expression are induced in the kidney by angiotensin and by nitric oxide inhibition. Kidney Int 2003; 64(Suppl 86): S46-S51.
84. Pockley AG, De Faire U, Kiessling R, Lemne C, Thulin T, Frostegard J. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens 2002; 20: 1815-1820.
85. Pockley AG, Georgiades A, Thulin T, de Faire U, Frostegard J. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 2003; 42: 235-238.
86. Parra G, Quiroz Y, Salazar J, Bravo Y, Pons H, Chavez M, Johnson RJ, Rodriguez-Iturbe B. Experimental induction of salt-sensitive hypertension is associated with lymphocyte proliferative response to HSP70. Kidney Int Suppl. 2008;111: S55-S59
87. Romero F, Yaguas K, Quiroz Y, Johnson RJ, Rodŕguez-Iturbe B. Spontaneously hypertensive rats (SHR) develop renal heat shock protein 70 (HSP70) expression and serum anti-HSP70 antibodies (abstract). World Congress of Nephrology; 21-25 April 2007; Rio de Janeiro, Brazil (M-PO-0684). Proceedings of WCN 2007 p 246